Trial Profile
Evaluation of the Protection Activity of Microfine Ti02, Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With SU: Phase II Photoprovocation Test
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2017
Price :
$35
*
At a glance
- Drugs Bisoctrizole/titanium dioxide (Primary) ; Bisoctrizole; Titanium dioxide
- Indications Urticaria
- Focus Therapeutic Use
- Sponsors Orfagen
- 27 May 2014 New trial record